Vivek Reddy, MD, spoke to Cardiovascular Business about some of the biggest trends in electrophysiology today.

Late-breaking data out of EuroPCR focused on 420 patients treated with Boston Scientific's new coronary IVL catheter. Overall, the device was found to be both safe and effective for patients with severe CAD.

Baxdrostat, sold by AstraZeneca under the brand name Baxfendy, is now approved to treat hypertension in combination with other antihypertensive medications.

Boston Scientific has invested heavily in Georgia-based MiRus, a rising name in the competitive TAVR landscape.

Samuel Jones, MD, reviews some of the biggest concerns about a new Medicare payment model focused on heart failure care that goes live in 2027. 

The Acist Pro Diagnostic System provides real-time contrast tracking, customizable presets and on-screen troubleshooting.

The FDA is still investigating this issue. For now, the agency recommends considering alternative treatment options when possible.

The idea is spreading thanks to a new startup focused on providing support for cardiologists.

Particulate matter may be present in certain 1-liter containers of B. Braun Medical's Lactated Ringer's Injections. If this enters a patient's circulatory system, it could lead to a series of adverse events.

While Judge Gregory Carro ruled the search of a backpack worn by Luigi Mangione—the man accused of killing UnitedHealthcare CEO Brian Thompson—was unlawful, some of its key contents will still be allowed in at trial. 

The agency cited free speech as its reasoning for rescinding the long-standing policy. While in place, the rule barred companies that agreed to settlements with the Securities and Exchange Commission from publicly denying allegations made by regulators.